COVID-19 Vaccines for Specific Groups of People

Updated Sept. 22, 2023

On June 27, 2024, the CDC Director adopted the ACIP’s recommendations for use of 2024–2025 COVID-19 vaccines in people ages 6 months and older as approved or authorized by FDA. The 2024–2025 vaccines are expected to be available in fall 2024. This page will be updated at that time to align with the new recommendations. Learn more: www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.html

Vaccines Are Recommended for Everyone 6 months and Older

CDC recommends everyone 5 years and older get 1 updated COVID-19 vaccine to protect against serious illness.

Children aged 6 months – 4 years may need more than 1 dose of updated COVID-19 vaccine to be up to date.
People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccine.
People aged 65 years and older who received 1 dose of any updated 2023-2024 COVID-19 vaccine (Moderna, Pfizer-BioNTech or Novavax) should receive 1 additional dose of an updated COVID-19 vaccine at least 4 months after the previous updated dose. For more Novavax information, click or tap here.

Families and Children

Other Groups

Learn about underlying medical conditions that can increase your risk of becoming very sick with COVID-19.

Getting a Vaccine
No-cost vaccines through CDC Bridge Program

For Healthcare and Public Health

Use of COVID-19 Vaccines in the United States: Interim Clinical Considerations